2018年6月27日委员会实施条例（EU）2018/917修订了第540/2011号实施条例（EU），涉及延长活性物质α-氯氰菊酯、贝鲁布他胺、苯甲氧基、苯噻伐威、双芬酸、boscalid、溴苯腈、卡普坦、香芹酮、氯丙胺、环唑磷、地塞米松、乐果、二甲酰吗啉、敌草枯、乙烯利、乙氧磷的批准期，依托恶唑、法莫沙酮、芬胺酮、非那米磷、氟米恶嗪、氟沙司他滨、folpet、虫磺隆、甲酸酯、链状胶藻菌株: J1446，异恶唑酮，甲霜灵-m，甲氧威，甲氧基苯甲酰胺，米利布津，恶嘧磺隆，淡紫拟青霉251株，苯美地芬，磷铵，甲基嘧啶磷，丙氨甲脲，丙硫环唑，吡喹酮和s-异丙甲草胺（与欧洲经济区相关的文本。）

Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor (Text with EEA relevance.)